Pentavalent Single-Domain Antibodies Reduce Campylobacter jejuni Motility and Colonization in Chickens

• Ali Riazi,

  Affiliation AbCelex Technologies Inc., Toronto, Ontario, Canada

  ⨯
• Philippa C. R. Strong,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Russell Coleman,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Wangxue Chen,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Tomoko Hirama,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Henk van Faassen,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Matthew Henry,

  Affiliation Dow AgroSciences, Indianapolis, Indiana, United States of America

  ⨯
• Susan M. Logan,

  Affiliation Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Christine M. Szymanski,

  Affiliation Centennial Centre for Interdisciplinary Science, Department of Biological Sciences and Alberta Glycomics Centre, The University of Alberta, Edmonton, Alberta, Canada

  ⨯
• Roger MacKenzie,

  Affiliations Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada, Centennial Centre for Interdisciplinary Science, Department of Biological Sciences and Alberta Glycomics Centre, The University of Alberta, Edmonton, Alberta, Canada

  ⨯
• Mehdi Arbabi Ghahroudi

  * E-mail: mehdi.arbabi@nrc-cnrc.gc.ca

  Affiliations Human Health Therapeutics, National Research Council of Canada, Ottawa, Ontario, Canada, School of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada, Department of Biology, Carleton University, Ottawa, Ontario, Canada

  ⨯